138 related articles for article (PubMed ID: 21122639)
1. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing.
Gerrald KR; Dixon DL; Barnette DJ; Williams VG
J Clin Lipidol; 2010; 4(2):120-5. PubMed ID: 21122639
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a pharmacist-managed lipid clinic: in-person versus telephone.
Dolder NM; Dolder CR
J Am Pharm Assoc (2003); 2010; 50(3):375-8. PubMed ID: 20452911
[TBL] [Abstract][Full Text] [Related]
3. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
Shaffer J; Wexler LF
Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
Smith MC; Boldt AS; Walston CM; Zillich AJ
Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center.
Fabbio KL; Bradley M; Chrymko M
Ann Pharmacother; 2010 Jan; 44(1):50-6. PubMed ID: 20028961
[TBL] [Abstract][Full Text] [Related]
6. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
Kauffman AB; Olson KL; Youngblood ML; Zadvorny EB; Delate T; Merenich JA;
J Clin Lipidol; 2010; 4(3):173-80. PubMed ID: 21122649
[TBL] [Abstract][Full Text] [Related]
7. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
[TBL] [Abstract][Full Text] [Related]
8. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
Lee VW; Fan CS; Li AW; Chau AC
J Clin Pharm Ther; 2009 Aug; 34(4):407-14. PubMed ID: 19583673
[TBL] [Abstract][Full Text] [Related]
10. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
Till LT; Voris JC; Horst JB
J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
13. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
14. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
[TBL] [Abstract][Full Text] [Related]
15. Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.
Rehring TF; Stolcpart RS; Sandhoff BG; Merenich JA; Hollis HW
J Vasc Surg; 2006 Jun; 43(6):1205-10. PubMed ID: 16765240
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic impact of clinical pharmacy service on hyperlipidemic management in Hong Kong.
Chung JS; Lee KK; Tomlinson B; Lee VW
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):43-52. PubMed ID: 20924095
[TBL] [Abstract][Full Text] [Related]
17. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
18. Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
Khanal S; Obeidat O; Hudson MP; Al-Mallah M; Bloome M; Lu M; Greenbaum AB; Kugelmass AD; Weaver WD
Am J Med; 2007 Aug; 120(8):734.e11-7. PubMed ID: 17679135
[TBL] [Abstract][Full Text] [Related]
19. Achieving cholesterol target in a managed care organization (ACTION) trial.
Straka RJ; Taheri R; Cooper SL; Smith JC
Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]